It was previously reported that JQ1 synergized with olaparib in BRCA1/2 wild-type ovarian cancer both in vitro and in vivo and correlated with the suppression of TOPBP1 and WEE1 [19]. This evidence concerns the gene TOPBP1 and ovarian cancer.